Back
Akari Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
37
AKTX
Akari Therapeutics PLC
Last Price:
1.53
Seasonality Move:
-11.19%
Buy
64
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.10
Seasonality Move:
-1.36%
Sell
37
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $1.48. The Score for AKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.20. The Score for ADAP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.48
The current trend is relatively stagnant and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
AKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 50.7 | Buy |
Chaikin Money Flow: | -4969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.54) | Buy |
Bollinger Bands (100): | (1.48 - 2.7) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.69 | Buy |
Chaikin Money Flow: | -609154 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.03 - 1.19) | Buy |
Bollinger Bands (100): | (0.87 - 1.47) | Buy |
AKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.51 | Sell |
20-day SMA: | 1.4 | Buy |
50-day SMA: | 1.56 | Sell |
200-day SMA: | 2.83 | Sell |
8-day EMA: | 1.49 | Sell |
20-day EMA: | 1.45 | Buy |
50-day EMA: | 1.62 | Sell |
200-day EMA: | 3.06 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Buy |
20-day SMA: | 1.13 | Buy |
50-day SMA: | 1.28 | Sell |
200-day SMA: | 0.91 | Buy |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.17 | Buy |
50-day EMA: | 1.2 | Buy |
200-day EMA: | 1.09 | Buy |
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
Akari Therapeutics PLC Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |